181 related articles for article (PubMed ID: 34572577)
1. Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors.
Lee S
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572577
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
3. N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.
Lee SM; Booe JM; Gingell JJ; Sjoelund V; Hay DL; Pioszak AA
Biochemistry; 2017 Jul; 56(26):3380-3393. PubMed ID: 28614667
[TBL] [Abstract][Full Text] [Related]
4. Asn-linked N-acetylglucosamine of the amylin receptor 2 extracellular domain enhances peptide ligand affinity.
Lee S
FEBS Open Bio; 2021 Jan; 11(1):195-206. PubMed ID: 33227824
[TBL] [Abstract][Full Text] [Related]
5. Molecular interaction of an antagonistic amylin analog with the extracellular domain of receptor activity-modifying protein 2 assessed by fluorescence polarization.
Lee S; Pioszak AA
Biophys Chem; 2020 Dec; 267():106477. PubMed ID: 33137565
[TBL] [Abstract][Full Text] [Related]
6. Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography.
Johansson E; Hansen JL; Hansen AM; Shaw AC; Becker P; Schäffer L; Reedtz-Runge S
J Biol Chem; 2016 Jun; 291(26):13689-98. PubMed ID: 27189946
[TBL] [Abstract][Full Text] [Related]
7. Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice.
Zakariassen HL; John LM; Lykkesfeldt J; Raun K; Glendorf T; Schaffer L; Lundh S; Secher A; Lutz TA; Le Foll C
Neuropharmacology; 2020 May; 167():107987. PubMed ID: 32035146
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin Receptor N-Glycosylation Enhances Peptide Hormone Affinity by Controlling Receptor Dynamics.
Lee SM; Jeong Y; Simms J; Warner ML; Poyner DR; Chung KY; Pioszak AA
J Mol Biol; 2020 Mar; 432(7):1996-2014. PubMed ID: 32035902
[TBL] [Abstract][Full Text] [Related]
9. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
10. A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice.
Arrigoni S; Le Foll C; Cabak A; Lundh S; Raun K; John LM; Lutz TA
Eur J Neurosci; 2021 Aug; 54(3):4863-4876. PubMed ID: 34189795
[TBL] [Abstract][Full Text] [Related]
11. Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor.
Pham V; Wade JD; Purdue BW; Sexton PM
J Biol Chem; 2004 Feb; 279(8):6720-9. PubMed ID: 14623894
[TBL] [Abstract][Full Text] [Related]
12. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
[TBL] [Abstract][Full Text] [Related]
14. Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.
Pozvek G; Hilton JM; Quiza M; Houssami S; Sexton PM
Mol Pharmacol; 1997 Apr; 51(4):658-65. PubMed ID: 9106632
[TBL] [Abstract][Full Text] [Related]
15. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Hay DL; Garelja ML; Poyner DR; Walker CS
Br J Pharmacol; 2018 Jan; 175(1):3-17. PubMed ID: 29059473
[TBL] [Abstract][Full Text] [Related]
16. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
[TBL] [Abstract][Full Text] [Related]
17. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
[TBL] [Abstract][Full Text] [Related]
18. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagoshi Y; Eto T
Biochem Biophys Res Commun; 2003 Feb; 301(2):460-4. PubMed ID: 12565884
[TBL] [Abstract][Full Text] [Related]
19. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes.
Hay DL; Christopoulos G; Christopoulos A; Poyner DR; Sexton PM
Mol Pharmacol; 2005 May; 67(5):1655-65. PubMed ID: 15692146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
